Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 1, 2012, Pages 235-242

  Sanguineti, Giuseppe ^a,b   Sormani, Maria Pia ^d   Marur, Shanthi ^c   Gunn, G Brandon ^a   Rao, Nikhil ^a   Cianchetti, Marco ^a   Ricchetti, Francesco ^b   McNutt, Todd ^b   Wu, Binbin ^b   Forastiere, Arlene ^c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Chemotherapy; Intensity modulated radiation therapy; Mucositis

Indexed keywords

ACUTE TOXICITY; CONFIDENCE INTERVAL; DOSE LEVELS; DOSE-VOLUME HISTOGRAMS; HIGHLY-CORRELATED; INDEPENDENT PREDICTORS; INDUCTION CHEMOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; MUCOSITIS; MULTI VARIATE ANALYSIS; NECK TREATMENTS; NONOVERLAPPING; ODDS RATIOS; ORAL MUCOSA; OROPHARYNGEAL CANCER; RADIATION ONCOLOGISTS;

CHEMOTHERAPY; DISEASES; PATIENT MONITORING; RADIOTHERAPY; TOXICITY;

PHYSICAL THERAPY;

CARBOPLATIN; CETUXIMAB; CISPLATIN; DASATINIB; DOCETAXEL; FLUOROURACIL; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; DOSE VOLUME HISTOGRAM; FEMALE; HISTOGRAM; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MOUTH MUCOSA; MUCOSA INFLAMMATION; OROPHARYNX CANCER; PREDICTION; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; CONFIDENCE INTERVALS; FEMALE; FLUOROURACIL; HUMANS; INDUCTION CHEMOTHERAPY; MALE; MIDDLE AGED; MOUTH MUCOSA; ODDS RATIO; ORGANS AT RISK; OROPHARYNGEAL NEOPLASMS; PYRIMIDINES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; STOMATITIS; TAXOIDS; THIAZOLES; TUMOR BURDEN;

EID: 84859835751     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.06.2000     Document Type: Article

References (33)

1. V. Gregoire, W. De Neve, and A. Eisbruch Intensity-modulated radiation therapy for head and neck carcinoma Oncologist 12 2007 555 564
2. A. Eisbruch, J. Harris, and A.S. Garden Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22) Int J Radiat Oncol Biol Phys 76 2010 1333 1338
3. Nutting C, A'Hern R, Rogers MS, et al. First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537; CRUK/03/005). J Clin Oncol (Meeting Abstracts) 2009;27:LBA6006.
4. F.M. Fang, C.Y. Chien, and W.L. Tsai Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy: A longitudinal study Int J Radiat Oncol Biol Phys 72 2008 356 364
5. D.I. Rosenthal, T.R. Mendoza, and M.S. Chambers Measuring head and neck cancer symptom burden: The development and validation of the M. D. Anderson symptom inventory, head and neck module Head Neck 29 2007 923 931
6. J.W. Denham, L.J. Peters, and J. Johansen Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer? Radiother Oncol 52 1999 157 164
7. I.H. Lee, and A. Eisbruch Mucositis versus tumor control: The therapeutic index of adding chemotherapy to irradiation of head and neck cancer Int J Radiat Oncol Biol Phys 75 2009 1060 1063
8. G. Sanguineti, E.J. Endres, and B.G. Gunn Is there a "mucosa- sparing" benefit of IMRT for head-and-neck cancer? Int J Radiat Oncol Biol Phys 66 2006 931 938
9. G. Sanguineti, G.B. Gunn, and B.C. Parker Weekly dose-volume parameters of mucosa and constrictor muscles predict the use of percutaneous endoscopic gastrostomy during exclusive intensity-modulated radiotherapy for oropharyngeal cancer Int J Radiat Oncol Biol Phys 79 2011 52 59
10. G.B. Gunn, E.J. Endres, and B. Parker A phase I/II study of altered fractionated IMRT alone for intermediate T-stage oropharyngeal carcinoma Strahlenther Onkol 186 2010 489 495
11. G. Sanguineti, G.B. Gunn, and E.J. Endres Patterns of locoregional failure after exclusive IMRT for oropharyngeal carcinoma Int J Radiat Oncol Biol Phys 72 2008 737 746
12. G. Sanguineti, P. Adapala, and E.J. Endres Dosimetric predictors of laryngeal edema Int J Radiat Oncol Biol Phys 68 2007 741 749
13. F. Ricchetti, B.B. Wu, and T. McNutt Volumetric change of selected organs at risk during IMRT for oropharyngeal cancer Int J Radiat Oncol Biol Phys 80 2011 161 168
14. A. Trotti Toxicity in head and neck cancer: A review of trends and issues Int J Radiat Oncol Biol Phys 47 2000 1 12
15. L.S. Elting, C.D. Cooksley, and M.S. Chambers Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies Int J Radiat Oncol Biol Phys 68 2007 1110 1120
16. M. Vera-Llonch, G. Oster, and M. Hagiwara Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma Cancer 106 2006 329 336
17. J.E. Clarkson, H.V. Worthington, and O.B. Eden Interventions for preventing oral mucositis for patients with cancer receiving treatment Cochrane Database Syst Rev 2003 CD000978
18. A.S. Garden, and M.S. Chambers Head and neck radiation and mucositis Curr Opin Support Palliat Care 1 2007 30 34
19. M.L. Hensley, K.L. Hagerty, and T. Kewalramani American Society of Clinical Oncology 2008 clinical practice guideline update: Use of chemotherapy and radiation therapy protectants J Clin Oncol 27 2009 127 145
20. S. Narayan, J. Lehmann, and M.A. Coleman Prospective evaluation to establish a dose response for clinical oral mucositis in patients undergoing head-and-neck conformal radiotherapy Int J Radiat Oncol Biol Phys 72 2008 756 762
21. J. Werbrouck, K. De Ruyck, and F. Duprez Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: Influence of dose and association with genetic polymorphisms in DNA DSB repair genes Int J Radiat Oncol Biol Phys 73 2009 1187 1195
22. S.M. Bentzen, and A. Trotti Evaluation of early and late toxicities in chemoradiation trials J Clin Oncol 25 2007 4096 4103
23. K.K. Fu, T.F. Pajak, and A. Trotti A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003 Int J Radiat Oncol Biol Phys 48 2000 7 16
24. K.K. Ang, L.J. Peters, and R.S. Weber Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx Int J Radiat Oncol Biol Phys 19 1990 1339 1345
25. A.A. Khalil, S.M. Bentzen, and J. Bernier Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas Int J Radiat Oncol Biol Phys 55 2003 568 575
26. S.M. Bentzen, M.I. Saunders, and S. Dische Radiotherapy-related early morbidity in head and neck cancer: Quantitative clinical radiobiology as deduced from the CHART trial Radiother Oncol 60 2001 123 135
27. B.F. Werbrouck, W.J. Pauwels, and J.L. De Bleecker A case of 5-fluorouracil-induced peripheral neuropathy Clin Toxicol 46 2008 264 266
28. J.H. Kaanders, A.J. van der Kogel, and K.K. Ang Altered fractionation: Limited by mucosal reactions? Radiother Oncol 50 1999 247 260
29. L.S. Elting, D.M. Keefe, and S.T. Sonis Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: Demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life Cancer 113 2008 2704 2713
30. J.B. Epstein, J.L. Beaumont, and C.K. Gwede Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer: A patient-reported outcomes questionnaire Cancer 109 2007 1914 1922
31. D. Rades, S. Kronemann, and T. Meyners Comparison of four cisplatin-based radiochemotherapy regimens for nonmetastatic stage III/IV squamous cell carcinoma of the head and neck Int J Radiat Oncol Biol Phys 80 2011 1037 1044
32. G. Sanguineti, A. Richetti, and M. Bignardi Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: Results of a multicenter Phase III study Int J Radiat Oncol Biol Phys 61 2005 762 771
33. C. Fakhry, and M.L. Gillison Clinical implications of human papillomavirus in head and neck cancers J Clin Oncol 24 2006 2606 2611